Sensorion (XPAR:ALSEN) Net Change in Cash : €29.80 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Sensorion Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Sensorion's Net Change in Cash for the six months ended in Dec. 2024 was €-20.58 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was €29.80 Mil.

Sensorion Net Change in Cash Historical Data

The historical data trend for Sensorion's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensorion Net Change in Cash Chart

Sensorion Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

31.75

-12.17

-23.80

10.77

29.80

Sensorion Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															-12.80	-11.76	22.53	50.37	-20.58

Sensorion Net Change in Cash Calculation

Sensorion's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-21.33	+	-11.135	+	62.261	+	0
	=	29.80

Sensorion's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -9.344 + -10.642 + -0.591 + 0.001

= -20.58

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €29.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sensorion Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Sensorion's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensorion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensorion SA (XPAR:ALSEN) » Definitions » Net Change in Cash

Comparable Companies

XPAR:ADOC XPAR:TNG XPAR:ABNX XPAR:ALGAE XPAR:SIGHT XPAR:MAAT XPAR:ALGEN XPAR:POXEL XPAR:ALDVI XPAR:AELIS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270

Traded in Other Exchanges

RFM:Germany

Address

375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080

Website

https://www.sensorion.com/en

Sensorion SA is a France-based clinical-stage biotech company dedicated to developing therapies to restore, treat, and prevent hearing loss. The company's product is in phase 2a clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies. The Company does business in a single operating segment: conducting research and development to discover drugs to treat inner ear disorders with a view to their future marketing. The company's pipeline programs are SENS-401 SSNHL, SENS-401 CIO, GJB2-GT, GJB2-GT, SENS-401 Cochlear, and others.

Sensorion Headlines

No Headlines